Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Lux Research Announces First Quarter Update of Lux Nanotech Index™

Lux Research Announces First Quarter Update of Lux Nanotech Index™

Lux Research

New York, NY | Posted on April 03, 2006

Lux Research, the world’s leading nanotechnology research and advisory firm, today announced its quarterly update to the Lux Nanotech Index™. The Index serves as a benchmark for the value that markets ascribe to emerging nanotechnology and forms the basis of the $93 million PowerShares Lux Nanotech Portfolio (AMEX:PXN), the first nanotechnology exchange-traded fund (ETF).

The components of the Lux Nanotech Index™ are split into two groups: 1) nanotech specialists – small and mid-sized companies that focus specifically on developing or funding emerging nanotechnology applications, and 2) end-use incumbents – large companies that are applying nanotechnology to existing product lines. Nanotech specialists account for 75% of the modified equal-dollar-weighted index; end-use incumbents account for 25%.

This update replaces Westaim with NUCRYST Pharmaceuticals among the nanotech specialists. NUCRYST, which develops therapeutic applications of silver nanoparticles, was a business unit of Westaim before it was spun off in a late December 2005 IPO; with the spinoff, Westaim’s nanotech commercialization activities have been divested. “The Acticoat antimicrobial bandages that NUCRYST developed with partner Smith & Nephew form a great example of how nanotechnology is changing products and shifting market shares today,” said Lux Research President and Director of Research Matthew M. Nordan.

The PowerShares Lux Nanotech Portfolio, which is based on the Index, is up 19.90% since its introduction in October 2005 and now has more than $93 million in assets under management. The Lux Nanotech Index™ is intended to be representative, and is not specifically designed to outperform the Nasdaq or other indices.

The components of the Lux Nanotech Index™ are:

Nanotech specialists

  • Accelrys (ACCL)
  • Altair Nanotechnologies (ALTI)
  • American Pharmaceutical Partners (APPX)
  • Arrowhead Research (ARWR)
  • Biosante Pharmaceuticals (BPA)
  • Elan (ELN)
  • FEI Company (FEIC)
  • Flamel Technologies (FLML)
  • Headwaters (HW)
  • Immunicon (IMMC)
  • Nanophase Technologies (NANX)
  • NUCRYST Pharmaceuticals (NCST)
  • NVE Corporation (NVEC)
  • Cambridge Display Technology (OLED)
  • Symyx Technologies (SMMX)
  • Harris & Harris Group (TINY)
  • Veeco Instruments (VECO)

End-use incumbents

  • Air Products & Chemicals (APD)
  • BASF (BF)
  • E.I. Du Pont de Nemours & Company (DD)
  • General Electric (GE)
  • Hewlett-Packard (HPQ)
  • Intel (INTC)
  • International Business Machines (IBM)
  • 3M (MMM)
  • Toyota (TM)

Full details on the Lux Nanotech Index™ are available at www.luxresearchinc.com/luxni.html.

####

About Lux Research:
Lux Research is the world’s leading nanotechnology research and advisory firm. We help our clients make better decisions to profit from nanoscale science and technology, tapping into our analysts’ unique expertise and unrivaled network. Our clients include top decision makers at large corporations, portfolio managers and analysts at leading financial institutions, CEOs of the most innovative start-ups, and visionary public policy makers.

For more information, please click here.

Contact:
Lux Research Inc.
Peter Hebert
646-723-0702
peter.hebert@luxresearchinc.com

Copyright © Lux Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanometrics Announces Upcoming Investor Events August 3rd, 2017

Nanometrics to Participate in the 9th Annual CEO Investor Summit 2017: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2017 in San Francisco June 27th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Announcements

Creation of coherent states in molecules by incoherent electrons October 21st, 2017

Novel 'converter' heralds breakthrough in ultra-fast data processing at nanoscale: Invention bagged four patents and could potentially make microprocessor chips work 1,000 times faster October 20th, 2017

Strange but true: turning a material upside down can sometimes make it softer October 20th, 2017

Leti Coordinating Project to Develop Innovative Drivetrains for 3rd-generation Electric Vehicles: CEA Tech’s Contribution Includes Liten’s Knowhow in Magnetic Materials and Simulation And Leti’s Expertise in Wide-bandgap Semiconductors October 20th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project